Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Yoshida

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Clinical and Translational Gastroenterology|May 13, 2025
Risk Stratification for Malignant Potential of Intraductal Papillary Mucinous Neoplasms Using the Apolipoprotein-A2 Isoforms Blood TestYuta Hasegawa, Norio Itokawa, Ayumi Kashiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2015
mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T CellsDaisuke Ito, Satoshi Nojima, Masayuki Nishide, et al.
Brain, Behavior, & Immunity - Health|April 3, 2023
Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in JapanTomohiro Nakao, Keitaro Murayama, Haruhisa Fukuda, et al.
Hepatology Communications|August 30, 2022
Antifibrotic effect and long-term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitusTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 5, 2025
Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes MellitusTaeang Arai, Masanori Atsukawa, Chikako Nagao, et al.
Scientific Reports|August 6, 2021
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver diseaseTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
Frontiers in Immunology|March 11, 2021
Increased Frequency of Dysfunctional Siglec-7<sup>-</sup>CD57<sup>+</sup>PD-1<sup>+</sup> Natural Killer Cells in Patients With Non-alcoholic Fatty Liver DiseaseYuzuru Sakamoto, Sachiyo Yoshio, Hiroyoshi Doi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2020
Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterizationMasanori Atsukawa, Akihito Tsubota, Masaru Hatano, et al.
Scientific Reports|May 12, 2016
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activationKeiko Morimoto, Yoshihiro Baba, Hisaaki Shinohara, et al.
Journal of Autoimmunity|December 29, 2018
Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smokingTakuro Nii, Kentaro Kuzuya, Daijiro Kabata, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Clinical and Translational Gastroenterology|May 13, 2025
Risk Stratification for Malignant Potential of Intraductal Papillary Mucinous Neoplasms Using the Apolipoprotein-A2 Isoforms Blood TestYuta Hasegawa, Norio Itokawa, Ayumi Kashiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2015
mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T CellsDaisuke Ito, Satoshi Nojima, Masayuki Nishide, et al.
Brain, Behavior, & Immunity - Health|April 3, 2023
Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in JapanTomohiro Nakao, Keitaro Murayama, Haruhisa Fukuda, et al.
Hepatology Communications|August 30, 2022
Antifibrotic effect and long-term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitusTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 5, 2025
Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes MellitusTaeang Arai, Masanori Atsukawa, Chikako Nagao, et al.
Scientific Reports|August 6, 2021
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver diseaseTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
Frontiers in Immunology|March 11, 2021
Increased Frequency of Dysfunctional Siglec-7<sup>-</sup>CD57<sup>+</sup>PD-1<sup>+</sup> Natural Killer Cells in Patients With Non-alcoholic Fatty Liver DiseaseYuzuru Sakamoto, Sachiyo Yoshio, Hiroyoshi Doi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2020
Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterizationMasanori Atsukawa, Akihito Tsubota, Masaru Hatano, et al.
Scientific Reports|May 12, 2016
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activationKeiko Morimoto, Yoshihiro Baba, Hisaaki Shinohara, et al.
Journal of Autoimmunity|December 29, 2018
Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smokingTakuro Nii, Kentaro Kuzuya, Daijiro Kabata, et al.
Pageof 10